These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 2266756)

  • 1. Hepatic antipyrine metabolism in athletes.
    Orioli S; Bandinelli I; Birardi A; Chieca R; Buzzelli G; Chiarantini E
    J Sports Med Phys Fitness; 1990 Sep; 30(3):261-3. PubMed ID: 2266756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in metabolism and urinary excretion of antipyrine induced by aerobic conditioning.
    Villa JG; Bayon JE; González-Gallego J
    J Sports Med Phys Fitness; 1999 Sep; 39(3):197-201. PubMed ID: 10573660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of physical exercise on one-sample antipyrine clearance.
    Fabbri A; Bianchi G; Zoli M; Marchi E; Marchesini G
    Ital J Gastroenterol; 1991 Feb; 23(2):74-6. PubMed ID: 1747507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical exercise and improvement of liver oxidative metabolism in the elderly.
    Mauriz JL; Tabernero B; García-López J; Jorquera F; Villa JG; González-Gallego J
    Eur J Appl Physiol; 2000 Jan; 81(1-2):62-6. PubMed ID: 10552268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oxidative hepatic metabolism in chronic alcoholics during the acute abstinence period: evaluation with antipyrine elimination].
    Soto Alvarez J; Alsar Ortiz MJ
    Rev Clin Esp; 1993 Jun; 193(2):60-3. PubMed ID: 8341815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipyrine metabolism and bronchogenic carcinoma.
    Ambre J; Graeff D; Bures F; Haupt D; Deason K
    J Med; 1977; 8(1):57-70. PubMed ID: 267157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of acute and chronic exercise on hepatic drug metabolism.
    Døssing M
    Clin Pharmacokinet; 1985; 10(5):426-31. PubMed ID: 3899456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease.
    Vuitton D; Miguet JP; Camelot G; Delafin C; Joanne C; Bechtel P; Gillet M; Carayon P
    Gastroenterology; 1981 Jan; 80(1):112-8. PubMed ID: 7450397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of prolonged oral cimetidine, ranitidine, and famotidine therapy on antipyrine elimination.
    Sakaue H; Akamatsu K; Hirabayashi Y; Sasaki T; Nakanishi K; Okada S; Kanaoka M; Nishinobu M; Masumoto S; Ohta Y
    Clin Ther; 1987; 9(6):602-6. PubMed ID: 2894244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipyrine metabolism and liver function in patients treated with high-dose medroxyprogesterone.
    Rautio A; Kauppila AJ; Tuimala RJ; Sotaniemi EA
    Biomedicine; 1979 Sep; 31(5):135-8. PubMed ID: 508896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipyrine clearance and its correlation to routine liver function tests in patients with liver disease.
    Krausz Y; Zylber-Katz E; Levy M
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):253-7. PubMed ID: 7450926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholestasis and hepatic drug metabolism. Comparison of metabolic clearance rate of antipyrine in patients with intrahepatic or extrahepatic cholestasis.
    Miguet JP; Vuitton D; Deschamps JP; Allemand H; Joanne C; Bechtel P; Carayon P
    Dig Dis Sci; 1981 Aug; 26(8):718-22. PubMed ID: 7261836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monooxigenase activity in liver diseases (study based on data of antipyrine metabolism)].
    Loginov AS; Bendikov EA; Kel'nia ZhA; Petrakov AV
    Ter Arkh; 1987; 59(2):84-9. PubMed ID: 3576485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver failure and drug metabolism.
    Andreasen PB; Ranek L
    Scand J Gastroenterol; 1975; 10(3):293-7. PubMed ID: 1138332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic antipyrine metabolism in malnourished patients: influence of the type of malnutrition and course after nutritional rehabilitation.
    Tranvouez JL; Lerebours E; Chretien P; Fouin-Fortunet H; Colin R
    Am J Clin Nutr; 1985 Jun; 41(6):1257-64. PubMed ID: 3923817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responses of distance runners and sprinters to exercise in a hot environment.
    Irion GL
    Aviat Space Environ Med; 1987 Oct; 58(10):948-53. PubMed ID: 3675466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of nifedipine, nitrendipine and verapamil at low concentration on antipyrine metabolism examined by extracorporeal rat liver perfusion.
    Szelag A; Magdalan J; Rutkowska M; Dziewiszek W; Trocha M; Rzepka M; Pieśniewska M; Fereniec L
    Pol J Pharmacol; 2003; 55(2):203-8. PubMed ID: 12926547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The metabolic clearance rate of antipyrine: a good index for the assessment of the hepatic drug-oxidizing function in cirrhotic patients (author's transl)].
    Miguet JP; Allemand H; Joanne C; Dhumeaux D
    Nouv Presse Med; 1978 Dec; 7(46):4209-11. PubMed ID: 745958
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatic drug metabolism and physical fitness.
    Boel J; Andersen LB; Rasmussen B; Hansen SH; Døssing M
    Clin Pharmacol Ther; 1984 Jul; 36(1):121-6. PubMed ID: 6734041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.